v3.25.2
Assets and Liabilities Held For Sale and Discontinued Operations - Schedule of Consolidated Statements of Operations (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Schedule of Consolidated Statements of Operations [Abstract]        
Revenue $ 605,530 $ 152,381 $ 1,220,093
Cost of goods sold 166,274 30,530 335,185
Gross profit 439,256 121,851 884,908
Expenses        
Depreciation 2,570 517 4,818
Marketing and promotion 587,893 6,924 849,415
Consulting fees 5,600 23,253
Office and administrative 7,661 515,619 54,875 1,261,767
Professional fees 109,436 50,460 246,068
Investor relations 390   7,057
Research and development 17,561 16,921 117,973
Foreign exchange (gain) loss 53 1,875 (1,198)
Travel and entertainment 52,505 10,726 111,613
Total expenses 7,661 1,291,627 142,298 2,620,766
Other income (expense)        
Other income 24,796 49,614 34,723
Interest expense (7,209) (11,574)
Loss on the sale of Skincare (39,676)
Net income (loss) from discontinued operations $ 17,135 $ (859,580) $ (10,509) $ (1,712,709)